- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
David Hoyt, MD, FACS, Describes the 4 Pillars of ACS' Quality Improvement Programs
David Hoyt, MD, FACS, executive director, American College of Surgeons (ACS), says the 4 pillars are based on 100 years of setting standards for healthcare.
David Hoyt, MD, FACS, executive director, American College of Surgeons (ACS), says the 4 pillars are based on 100 years of setting standards for healthcare. He adds that ACS has programs in trauma, bariatric surgery, breast surgery, and the National Surgical Quality Improvement Program (NSQIP).
“What we’ve learned from that, is really the 4 standards or the 4 pillars of being effective,” he says.
Dr Hoyt says that first you set standards—which is done through consensus or evidence. Second, you build out the infrastructure that’s required to achieve those standards. The third pillar is to commit to measuring performance against those standards, and remain accountable to those measurements. The final pillar is agreeing to a peer review against those standards.
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
How AI Can Address the Troubled Business Model in Oncology
July 7th 2025Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
